NervGen Pharma Corp.
NervGen Pharma Corp. (NGEN.V) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NGEN.V · as of Jun 9, 2026
Key Statistics
Explore NervGen Pharma Corp. Data
ngen.v stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
ngen.v competitorsNGEN.V
CYBN.NE
DR.TO
EPRX.TO
FRX.TO
HBP.TOStock Performance
Full HistoryAbout NervGen Pharma Corp.
NervGen Pharma Corp. along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions inv…
what is nervgen pharma corp. · ngen.v stock overview · nervgen pharma corp. company profile · who is nervgen pharma corp. ceo · ngen.v TSXV · nervgen pharma corp. headquarters · nervgen pharma corp. business segments
About Stock Overview & Key Data
NervGen Pharma Corp. (NGEN.V) is a Healthcare company in the Biotechnology industry, listed on TSXV since Mar 15, 2019. As of the latest trading session, NGEN.V stock price is $5.15, with a market capitalization of $407.9M. The stock has returned +72.24% over the past 12 months and -32.94% year-to-date.
According to 1 Wall Street analysts, the consensus rating for NervGen Pharma Corp. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, NervGen Pharma Corp. reported revenue of — and net income of -$44.1M. For detailed data — including NervGen Pharma Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NervGen Pharma Corp. (NGEN.V) stock price is $5.15. The stock is traded on TSXV under the ticker symbol NGEN.V. The 52-week range is $2.57 – $8.49.